Glenmark was among a wave of drugmakers that decided having U.S. manufacturing was a good hedge when FDA crackdowns on facilities in India was keeping some of them from exporting to the U.S. The Mumbai-based Glenmark will see if that bet pays off when a $100 million plants opens in North Carolina on Tuesday.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,